AAAAAA

   
Results: 1-25 | 26-50 | 51-70
Results: 1-25/70
DELAYED TARGETING OF CYTOKINE-NONRESPONSIVE HUMAN BONE-MARROW CD34(-MEDIATED GENE-TRANSFER ENHANCES TRANSDUCTION EFFICIENCY AND LONG-TERM EXPRESSION OF TRANSDUCED GENES() CELLS WITH RETROVIRUS)
Authors: VEENA P TRAYCOFF CM WILLIAMS DA MCMAHEL J RICE S CORNETTA K SROUR EF
Citation: P. Veena et al., DELAYED TARGETING OF CYTOKINE-NONRESPONSIVE HUMAN BONE-MARROW CD34(-MEDIATED GENE-TRANSFER ENHANCES TRANSDUCTION EFFICIENCY AND LONG-TERM EXPRESSION OF TRANSDUCED GENES() CELLS WITH RETROVIRUS), Blood, 91(10), 1998, pp. 3693-3701
DETECTION OF GERM-CELL TUMOR-CELLS IN APHERESIS PRODUCTS USING POLYMERASE CHAIN-REACTION
Authors: FAN Y EINHORN L SAXMAN S KATZ B ABONOUR R CORNETTA K
Citation: Y. Fan et al., DETECTION OF GERM-CELL TUMOR-CELLS IN APHERESIS PRODUCTS USING POLYMERASE CHAIN-REACTION, Clinical cancer research, 4(1), 1998, pp. 93-98
DETECTION OF GERM-CELL TUMOR-CELLS IN APHERESIS PRODUCTS USING POLYMERASE CHAIN-REACTION
Authors: FAN Y EINHORN L SAXMAN S KATZ B ABONOUR R CORNETTA K
Citation: Y. Fan et al., DETECTION OF GERM-CELL TUMOR-CELLS IN APHERESIS PRODUCTS USING POLYMERASE CHAIN-REACTION, Clinical cancer research, 4(1), 1998, pp. 93-98
HIGH-SPEED CENTRIFUGATION ENHANCES EFFICIENT RETROVIRAL-MEDIATED GENE-TRANSFER INTO MITOTICALLY QUIESCENT HUMAN HEMATOPOIETIC PROGENITOR CELLS
Authors: TONG X CORNETTA K TRAVCOFF CM SROUR EF
Citation: X. Tong et al., HIGH-SPEED CENTRIFUGATION ENHANCES EFFICIENT RETROVIRAL-MEDIATED GENE-TRANSFER INTO MITOTICALLY QUIESCENT HUMAN HEMATOPOIETIC PROGENITOR CELLS, Experimental hematology, 26(8), 1998, pp. 22-22
TREATMENT WITH FLT3 LIGAND TRANSDUCED C3L5 CELLS FOR MURINE BREAST-CANCER
Authors: BRAUN SE CHEN K ORAZI A BROXMEYER HE CORNETTA K
Citation: Se. Braun et al., TREATMENT WITH FLT3 LIGAND TRANSDUCED C3L5 CELLS FOR MURINE BREAST-CANCER, Experimental hematology, 26(8), 1998, pp. 456-456
RAPID ENGRAFTMENT AFTER ALLOGENEIC TRANSPLANTATION USING CD34-ENRICHED MARROW-CELLS
Authors: CORNETTA K GHARPURE V MILLS B HROMAS R ABONOUR R BROUN ER TRAYCOFF CM HANNA M WYMAN N DANIELSON C GONIN R KUNKEL L OLDHAM F SROUR EF
Citation: K. Cornetta et al., RAPID ENGRAFTMENT AFTER ALLOGENEIC TRANSPLANTATION USING CD34-ENRICHED MARROW-CELLS, Bone marrow transplantation, 21(1), 1998, pp. 65-71
DOSE-INTENSIFICATION OF PROCARBAZINE, CCNU (LOMUSTINE), VINCRISTINE (PCV) WITH PERIPHERAL-BLOOD STEM-CELL SUPPORT IN YOUNG-PATIENTS WITH GLIOMAS
Authors: JAKACKI RI JAMISON C MATHEWS VP HEILMAN DK DROPCHO E CORNETTA K MACDONALD DR WILLIAMS DA
Citation: Ri. Jakacki et al., DOSE-INTENSIFICATION OF PROCARBAZINE, CCNU (LOMUSTINE), VINCRISTINE (PCV) WITH PERIPHERAL-BLOOD STEM-CELL SUPPORT IN YOUNG-PATIENTS WITH GLIOMAS, Medical and pediatric oncology, 31(6), 1998, pp. 483-490
CHRONIC MYELOGENOUS LEUKEMIA CD34(-CYCLE MORE RAPIDLY THAN NORMAL MARROW CD34(+) CELLS() CELLS EXIT G(0)G(1) PHASES OF CELL)
Authors: TRAYCOFF CM HALSTEAD B RICE S MCMAHEL J SROUR EF CORNETTA K
Citation: Cm. Traycoff et al., CHRONIC MYELOGENOUS LEUKEMIA CD34(-CYCLE MORE RAPIDLY THAN NORMAL MARROW CD34(+) CELLS() CELLS EXIT G(0)G(1) PHASES OF CELL), British Journal of Haematology, 102(3), 1998, pp. 759-767
HIGH-DOSE CHEMOTHERAPY FOLLOWED BY REINFUSION OF SELECTED CD34(-BLOODCELLS IN PATIENTS WITH POOR-PROGNOSIS BREAST-CANCER - A RANDOMIZED MULTICENTER STUDY() PERIPHERAL)
Authors: CHABANNON C CORNETTA K LOTZ JP ROSENFELD C SHLOMCHIK M YANOVITCH S MAROLLEAU JP SLEDGE G NOVAKOVITCH G SROUR EF BURTNESS B CAMERLO J GRAVIS G LEEFISCHER J FAUCHER C CHABBERT I KRAUSE D MARANINCHI D MILLS B KUNKEL L OLDHAM F BLAISE D VIENS P
Citation: C. Chabannon et al., HIGH-DOSE CHEMOTHERAPY FOLLOWED BY REINFUSION OF SELECTED CD34(-BLOODCELLS IN PATIENTS WITH POOR-PROGNOSIS BREAST-CANCER - A RANDOMIZED MULTICENTER STUDY() PERIPHERAL), British Journal of Cancer, 78(7), 1998, pp. 913-921
A MULTICENTER STUDY OF PLATELET RECOVERY AND UTILIZATION IN PATIENTS AFTER MYELOABLATIVE THERAPY AND HEMATOPOIETIC STEM-CELL TRANSPLANTATION
Authors: BERNSTEIN SH NADEMANEE AP VOSE JM TRICOT G FAY JW NEGRIN RS DIPERSIO J RONDON G CHAMPLIN R BARNETT MJ CORNETTA K HERZIG GP VAUGHAN W GEILS G KEATING J MESSNER H WOLFF SN MILLER KB LINKER C CAIRO M HELLMANN S ASHBY M STRYKER S NASH RA
Citation: Sh. Bernstein et al., A MULTICENTER STUDY OF PLATELET RECOVERY AND UTILIZATION IN PATIENTS AFTER MYELOABLATIVE THERAPY AND HEMATOPOIETIC STEM-CELL TRANSPLANTATION, Blood, 91(9), 1998, pp. 3509-3517
GENE-THERAPY STRATEGIES FOR LEUKEMIA
Authors: BRAUN SE CHEN KY BATTIWALLA M CORNETTA K
Citation: Se. Braun et al., GENE-THERAPY STRATEGIES FOR LEUKEMIA, Molecular medicine today, 3(1), 1997, pp. 39-46
RETROVIRALLY MEDIATED GENE-TRANSFER OF ARG22 AND TYR22 FORMS OF DIHYDROFOLATE-REDUCTASE INTO THE HEMATOPOIETIC-CELL LINE K562 - A COMPARISON OF METHOTREXATE RESISTANCE
Authors: BRAUN SE MCIVOR RS DAVIDSON AS HANNA M TRAYCOFF CM BEREBETSKY DA GONIN R BROXMEYER HE CORNETTA K
Citation: Se. Braun et al., RETROVIRALLY MEDIATED GENE-TRANSFER OF ARG22 AND TYR22 FORMS OF DIHYDROFOLATE-REDUCTASE INTO THE HEMATOPOIETIC-CELL LINE K562 - A COMPARISON OF METHOTREXATE RESISTANCE, Cancer gene therapy, 4(1), 1997, pp. 26-32
THE 30 35 KDA CHYMOTRYPTIC FRAGMENT OF FIBRONECTIN ENHANCES RETROVIRAL-MEDIATED GENE-TRANSFER IN PURIFIED CHRONIC MYELOGENOUS LEUKEMIA BONE-MARROW PROGENITORS/
Authors: TRAYCOFF CM SROUR EF DUTT P FAN Y CORNETTA K
Citation: Cm. Traycoff et al., THE 30 35 KDA CHYMOTRYPTIC FRAGMENT OF FIBRONECTIN ENHANCES RETROVIRAL-MEDIATED GENE-TRANSFER IN PURIFIED CHRONIC MYELOGENOUS LEUKEMIA BONE-MARROW PROGENITORS/, Leukemia, 11(1), 1997, pp. 159-167
RETROVIRAL GENE-THERAPY IN HEMATOPOIETIC DISEASES
Authors: CORNETTA K FAN Y
Citation: K. Cornetta et Y. Fan, RETROVIRAL GENE-THERAPY IN HEMATOPOIETIC DISEASES, Journal of clinical apheresis, 12(4), 1997, pp. 187-193
RETROVIRAL-MEDIATED GENE-TRANSFER OF FLT3-LIGAND AND OTHER CYTOKINE GENES INTO PRIMARY STROMAL CELLS - EFFECTS ON THE ACTIVITY OF UMBILICAL-CORD BLOOD CD34-TERM CULTURES(+ CELLS IN LONG)
Authors: BALDUINI A BRAUN S CORNETTA K LYMAN S BROXMEYER HE
Citation: A. Balduini et al., RETROVIRAL-MEDIATED GENE-TRANSFER OF FLT3-LIGAND AND OTHER CYTOKINE GENES INTO PRIMARY STROMAL CELLS - EFFECTS ON THE ACTIVITY OF UMBILICAL-CORD BLOOD CD34-TERM CULTURES(+ CELLS IN LONG), Experimental hematology, 25(8), 1997, pp. 250-250
PREFERENTIAL SEQUESTRATION IN-VITRO OF BCR ABL-NEGATIVE HEMATOPOIETICPROGENITOR CELLS AMONG CYTOKINE NONRESPONSIVE CML-MARROW CD34(+) CELLS/
Authors: VEENA P CORNETTA K DAVIDSON A AGUERO B MCMAHEL J TRAYCOFF CM SROUR EF
Citation: P. Veena et al., PREFERENTIAL SEQUESTRATION IN-VITRO OF BCR ABL-NEGATIVE HEMATOPOIETICPROGENITOR CELLS AMONG CYTOKINE NONRESPONSIVE CML-MARROW CD34(+) CELLS/, Bone marrow transplantation, 19(12), 1997, pp. 1213-1221
OPTIMAL COLLECTION OF CD34+ BLOOD-CELLS
Authors: DANIELSON C ABONOUR R JACKSON L SKIPWORTH E GRAVES V CORNETTA K MCCARTHY L
Citation: C. Danielson et al., OPTIMAL COLLECTION OF CD34+ BLOOD-CELLS, Transfusion, 37(9), 1997, pp. 242-242
ANTITUMOR-ACTIVITY AND IMMUNOTHERAPEUTIC PROPERTIES OF FLT3-LIGAND INA MURINE BREAST-CANCER MODEL
Authors: CHEN KY BRAUN S LYMAN S FAN Y TRAYCOFF CM WIEBKE EA GADDY J SLEDGE G BROXMEYER HE CORNETTA K
Citation: Ky. Chen et al., ANTITUMOR-ACTIVITY AND IMMUNOTHERAPEUTIC PROPERTIES OF FLT3-LIGAND INA MURINE BREAST-CANCER MODEL, Cancer research, 57(16), 1997, pp. 3511-3516
TANDEM HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR INITIAL RELAPSE OF TESTICULAR GERM-CELL CANCER
Authors: BROUN ER NICHOLS CR GIZE G CORNETTA K HROMAS RA SCHACHT B EINHORN LH
Citation: Er. Broun et al., TANDEM HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR INITIAL RELAPSE OF TESTICULAR GERM-CELL CANCER, Cancer, 79(8), 1997, pp. 1605-1610
DETECTION OF GERM-CELL TUMOR-CELLS IN APHERESIS PRODUCTS USING POLYMERASE CHAIN-REACTION
Authors: FAN Y EINHORN L SAXMAN S KATZ B ABONOUR R CORNETTA K
Citation: Y. Fan et al., DETECTION OF GERM-CELL TUMOR-CELLS IN APHERESIS PRODUCTS USING POLYMERASE CHAIN-REACTION, Blood, 90(10), 1997, pp. 4327-4327
IMMUNE RECONSTITUTION FOLLOWING ALLOGENEIC TRANSPLANTATION USING CD34ENRICHED MARROW-CELLS
Authors: ABONOUR R KOTYLO PK GHARPURE V HROMAS R ROBERTSON MJ SROUR E CORNETTA K
Citation: R. Abonour et al., IMMUNE RECONSTITUTION FOLLOWING ALLOGENEIC TRANSPLANTATION USING CD34ENRICHED MARROW-CELLS, Blood, 90(10), 1997, pp. 4392-4392
AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOLLOWING MYELOABLATION WITH TOTAL-BODY IRRADIATION, MELPHALAN AND ETOPOSIDE FOR THE TREATMENT OF POOR-PROGNOSIS SOLID TUMORS IN CHILDREN AND ADULTS
Authors: EMANUEL D KREISSMAN S BREITFELD P ROBERTSON K LUCAS K SANDLER A CORNETTA K SMITH F
Citation: D. Emanuel et al., AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOLLOWING MYELOABLATION WITH TOTAL-BODY IRRADIATION, MELPHALAN AND ETOPOSIDE FOR THE TREATMENT OF POOR-PROGNOSIS SOLID TUMORS IN CHILDREN AND ADULTS, Blood, 90(10), 1997, pp. 4555-4555
A PILOT-STUDY OF ALLOGENIC CD34-BLOOD STEM-CELL TRANSPLANTATION (PBSCT) USING MISMATCHED RELATED DONORS FOR PATIENTS WITH ADVANCED HEMATOLOGIC MALIGNANCIES( PERIPHERAL)
Authors: LAPORT GF BENSINGER W DAUGHERTY CK YANOVICH S CORNETTA K SKIKNE BS PRETI RA COANTHO TA LISTER J MILLS BJ KUNKEL LA WILLIAMS SF LARSON RA
Citation: Gf. Laport et al., A PILOT-STUDY OF ALLOGENIC CD34-BLOOD STEM-CELL TRANSPLANTATION (PBSCT) USING MISMATCHED RELATED DONORS FOR PATIENTS WITH ADVANCED HEMATOLOGIC MALIGNANCIES( PERIPHERAL), Blood, 90(10), 1997, pp. 482-482
EFFICACY OF FLT3-LIGAND IN A MURINE LEUKEMIA MODEL
Authors: SONPAVDE G BRAUN S CHEN K LYMAN S CORNETTA K
Citation: G. Sonpavde et al., EFFICACY OF FLT3-LIGAND IN A MURINE LEUKEMIA MODEL, Blood, 90(10), 1997, pp. 827-827
POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISORDERS IN BONE-MARROW TRANSPLANT RECIPIENTS ARE AGGRESSIVE DISEASES WITH A HIGH-INCIDENCE OF ADVERSE HISTOLOGIC AND IMMUNOBIOLOGICAL FEATURES
Authors: ORAZI A HROMAS RA NEIMAN RS GREINER TC LEE CH RUBIN L HASKINS S HEEREMA NA GHARPURE V ABONOUR R SROUR EF CORNETTA K
Citation: A. Orazi et al., POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISORDERS IN BONE-MARROW TRANSPLANT RECIPIENTS ARE AGGRESSIVE DISEASES WITH A HIGH-INCIDENCE OF ADVERSE HISTOLOGIC AND IMMUNOBIOLOGICAL FEATURES, American journal of clinical pathology, 107(4), 1997, pp. 419-429
Risultati: 1-25 | 26-50 | 51-70